Diabetes 50:515-520, 2001
© 2001 by the American Diabetes Association, Inc.
Efficient Ex Vivo Transduction of Pancreatic Islet Cells With Recombinant Adeno-Associated Virus Vectors
Terence Flotte1,2,4,
Anupam Agarwal3,
Jianming Wang4,
Sihong Song4,
Elizabeth S. Fenjves7,
Luca Inverardi7,
Kye Chesnut1,2,
Sandra Afione8,
Scott Loiler4,
Clive Wasserfall5,
Matthias Kapturczak3,
Tamir Ellis5,
Harry Nick6, and
Mark Atkinson5
1 Genetics Institute
2 Powell Gene Therapy Center, and the
3 Departments of Medicine
4 Pediatrics
5 Pathology, and
6 Neuroscience, University of Florida, Gainesville
7 Diabetes Research Institute, University of Miami, Miami, Florida
8 Molecular Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland
The ability to transfer immunoregulatory, cytoprotective, or antiapoptotic genes into pancreatic islet cells may allow enhanced posttransplantation survival of islet allografts and inhibition of recurrent autoimmune destruction of these cells in type 1 diabetes. However, transient transgene expression and the tendency to induce host inflammatory responses have limited previous gene delivery studies using viral transfer vectors. We demonstrate here that recombinant adeno-associated virus (rAAV) serotype 2, a vector that can overcome these limitations, effectively transduces both human and murine pancreatic islet cells with reporter genes as well as potentially important immunoregulatory cytokine genes (interleukin-4, interleukin-10), although a very high multiplicity of infection (10,000 infectious units/islet equivalent) was required. This requirement was alleviated by switching to rAAV serotype 5, which efficiently transduced islets at a multiplicity of infection of 100. Although adenovirus (Ad) coinfection was required for efficient ex vivo expression at early time points, islets transduced without Ad expressed efficiently when they were transplanted under the renal capsule and allowed to survive in vivo. The rAAV-delivered transgenes did not interfere with islet cell insulin production and were expressed in both ß- and nonß-cells. We believe rAAV will provide a useful tool to deliver therapeutic genes for modulating immune responses against islet cells and markedly enhance long-term graft survival.
Abbreviations:
AAV, adeno-associated virus; Ad, adenovirus; CB, CMV enhancer/chicken ß actin hybrid; CMV, cytomegalovirus; GFP, green fluorescent protein; IL, interleukin; ITR, inverted terminal repeat; i.u., infectious units; MOI, multiplicity of infection; nlacZ, nuclear-targeted ß-galactosidase; PBS, phosphate-buffered saline; rAAV, recombinant AAV; rAAV2, rAAV serotype 2; rAAV5, rAAV serotype 5; RSV, Rous sarcoma virus; SV40, simian virus 40

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Govindasamy, E. Padron, R. McKenna, N. Muzyczka, N. Kaludov, J. A. Chiorini, and M. Agbandje-McKenna
Structurally Mapping the Diverse Phenotype of Adeno-Associated Virus Serotype 4
J. Virol.,
December 1, 2006;
80(23):
11556 - 11570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Narang and R. I. Mahato
Biological and biomaterial approaches for improved islet transplantation.
Pharmacol. Rev.,
June 1, 2006;
58(2):
194 - 243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chen, J.-h. Ding, R. Bekeredjian, B.-z. Yang, R. V. Shohet, S. A. Johnston, H. E. Hohmeier, C. B. Newgard, and P. A. Grayburn
Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology
PNAS,
May 30, 2006;
103(22):
8469 - 8474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Wang, T. Zhu, K. K. Rehman, S. Bertera, J. Zhang, C. Chen, G. Papworth, S. Watkins, M. Trucco, P. D. Robbins, et al.
Widespread and Stable Pancreatic Gene Transfer by Adeno-Associated Virus Vectors via Different Routes.
Diabetes,
April 1, 2006;
55(4):
875 - 884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S K Richards, L E Parton, I Leclerc, G A Rutter, and R M Smith
Over-expression of AMP-activated protein kinase impairs pancreatic {beta}-cell function in vivo
J. Endocrinol.,
November 1, 2005;
187(2):
225 - 235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. N. Samli, M. J. McGuire, C. B. Newgard, S. A. Johnston, and K. C. Brown
Peptide-Mediated Targeting of the Islets of Langerhans
Diabetes,
July 1, 2005;
54(7):
2103 - 2108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Barbu, G. Akusjarvi, and N. Welsh
Adenoviral-Mediated Transduction of Human Pancreatic Islets: Importance of Adenoviral Genome for Cell Viability and Association with a Deficient Antiviral Response
Endocrinology,
May 1, 2005;
146(5):
2406 - 2414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chen, A. Agarwal, O. Y. Glushakova, M. S. Jorgensen, S. K. Salgar, A. Poirier, T. R. Flotte, B. P. Croker, K. M. Madsen, M. A. Atkinson, et al.
Gene Delivery in Renal Tubular Epithelial Cells Using Recombinant Adeno-Associated Viral Vectors
J. Am. Soc. Nephrol.,
April 1, 2003;
14(4):
947 - 958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Yang, M. Chen, R. Wu, L. B. Fialkow, J. S. Bromberg, M. McDuffie, A. Naji, and J. L. Nadler
Suppression of Autoimmune Diabetes by Viral IL-10 Gene Transfer
J. Immunol.,
June 15, 2002;
168(12):
6479 - 6485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Goudy, S. Song, C. Wasserfall, Y. C. Zhang, M. Kapturczak, A. Muir, M. Powers, M. Scott-Jorgensen, M. Campbell-Thompson, J. M. Crawford, et al.
Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice
PNAS,
November 20, 2001;
98(24):
13913 - 13918.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Diabetes Association.
|
|
| |
|